Cardiology Update

AUGUST 4, 2024

The 2021 European Society of Cardiology guidelines recommend guideline-directed medical therapy (GDMT) for patients with HF with reduced ejection fraction (HFrEF). This includes beta-blockers, ACE inhibitors, ARBs, ARNIs, MRAs, and SGLT2 inhibitors.

Heart Failure 119

Heart Failure ACE Inhibitor COVID-19 Quality of Life 119

Open Heart

APRIL 24, 2024

Results Data were collected in April 2012 to January 2014 and in June 2021 to December 2022. were on a beta blocker and on an ACE inhibitor/angiotensin receptor blocker/angiotensin receptor-neprilysin inhibitor, respectively. Statistical significance is determined at p<0.05.

Heart Failure 52

Heart Failure Preserved Ejection Fraction ACE Inhibitor Pharmacology 52

Open Heart

NOVEMBER 8, 2023

Methods Randomised controlled trials (RCTs) were identified from Medline, Scopus up to June 2021. A network meta-analysis aimed to compare effects of both conventional and alternative drug combinations on time to develop primary composite outcome of cardiovascular death or heart failure hospitalisation (PCO).

Heart Failure 52

Heart Failure ACE Inhibitor Outcomes Pharmacology 52

Open Heart

FEBRUARY 17, 2024

Design A cross-sectional design with self-administered questionnaire with data collected between October 2021 and September 2022. were on ACE inhibitors/angiotensin receptor blockers and 54.9% Confirmation of cases was done through the ejection fraction, medication list and frequent symptoms of the patients. The mean age was 61.3±17.36

Heart Failure 40

Heart Failure Quality of Life ACE Inhibitor COVID-19 40

Physiologically Speaking

MARCH 6, 2024

ACE inhibitors block the angiotensin-converting enzyme to reduce blood pressure. Hawley - 2021 - The Journal of Physiology - Wiley Online Library While an exercise pill could certainly activate one or a few of the pathways in the body that exercise does, the scope would be extremely narrow. .” Statins lower cholesterol.

Exercise 92

Exercise Blood Pressure Risk Factors Physiology 92

Dr. Smith's ECG Blog

NOVEMBER 15, 2023

associated typical Myocardial Infarction therapies such as statins and ACE inhibitors with significantly decreased 1 year mortality in MINOCA patients, which suggests that they do indeed have a similar pathophysiology to MI patients with obstructive coronary disease. Lindahl et al.

Coronary Angiogram 109

Coronary Angiogram Plaque Thrombosis STEMI 109

EMS 12-Lead

MAY 8, 2022

ACE inhibitors, or potassium-sparing diuretics), are particularly susceptible. This ECG is pathognomonic for hyperkalemia. Predisposition to hyperkalemia is complex, but in general, patients with renal disease, or those taking medications that yield potassium retention (e.g. Even the preserved QRS duration is at risk of imminent death.

ACE Inhibitor 52

ACE Inhibitor Ischemia STEMI Physiology 52